Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Herceptin + Standard Chemo in HER2+ Metastatic Gastric Cancer
NCT01260194Phase 4Terminated
- Sponsor
- Roche
- Start
- Jun 2011
- Primary completion
- Jan 2015
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of trastuzumab in gastric cancer (GC), gastroesophageal junction adenocarcinoma, sponsored by Roche. Started Jun 2011; status: terminated.
02
Drugs
03
Conditions
gastric cancer (GC)gastroesophageal junction adenocarcinoma
Beyond the preview
Go deeper on NCT01260194.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01260194.